Strobeck Matthew bought BDSX
January 2, 2026 · Form 4 insider transaction
Strobeck Matthew bought 6,354 shares of Biodesix, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,354
Price
$0.00
Total value
N/A
InsiderStrobeck Matthew
RoleDirector
CompanyBiodesix, Inc. (BDSX)
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after6,354
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer.